Latest DRC News
- Details
Jennifer Pollock, Ph.D., professor in the Department of Medicine, has been named the latest recipient of the school’s Featured Discovery award. This recognition celebrates notable research contributions made by faculty and highlights the impact of their scientific advancements.
- Details
A new tool in understanding and improving nutrition for all now resides at the University of Alabama at Birmingham. The Department of Nutrition Sciences is now home to a brand-new metabolic kitchen and a teaching kitchen, which will significantly enhance the department’s research, education, clinical and community outreach capabilities.
- Details
A new combination drug therapy is showing extraordinary promise in the bout against obesity, helping patients lose an average of 20 percent of their body weight in a major clinical trial.
- Details
Nine UAB faculty members elevated to Distinguished and University professorships
- Details
UAB Comprehensive Diabetes Center (UCDC) members and trainees will share their latest scientific findings at the world’s largest diabetes conference, the American Diabetes Association (ADA) 85th Scientific Sessions, June 20-23, at the McCormick Place Convention Center in Chicago.
- Details
Ananda Basu, MBBS, MD, FRCP, M.D., has been selected as the director of the UAB Diabetes Research Center. His primary appointment will remain in the Heersink School of Medicine as the S. Richardson Hill, Jr. Endowed Professor of Endocrinology and director of the UAB Diabetes Technology Program. He will have a secondary appointment in the Department of Nutrition Sciences.
- Details
Weight loss medications have dramatically transformed obesity treatment, but there's a surprising trend emerging: many patients who find success on these drugs are stopping them. Why? And what happens next?
- Details
W. Timothy Garvey, M.D., a professor at the University of Alabama at Birmingham, was awarded the Gerald Reaven Distinguished Leader in Insulin Resistance Award by the World Congress on Insulin Resistance, Diabetes and Cardiovascular Disease. Garvey, known for developing Cardiometabolic Disease Staging, helps clinicians assess risk for Type 2 diabetes and cardiovascular disease, guiding treatment and weight loss therapy decisions.
- Details
W. Timothy Garvey, M.D., a professor at the University of Alabama at Birmingham, recently contributed to a groundbreaking global commission that called for a major overhaul of obesity diagnoses, recommending a shift away from relying solely on body mass index, or BMI, to more accurately define obesity as a disease.
- Details
Researchers from the University of Alabama at Birmingham Marnix E. Heersink School of Medicine have published a study in JACC: Heart Failure that sheds light on how managing cardiovascular risk factors can influence health outcomes in carriers of the transthyretin V142I variant.